Fodosine forodesine hydrochloride: Phase IIa data

In an open-label, international Phase IIa in 23 patients, IV Fodosine led to an overall response rate of 35%, with 5 complete responses (22%) and 3 partial responses (13%). Treatment was well tolerate...